GGrantIndex
Sort

64,565 grants matching drug discovery

Genome-Wide RNAi Screen for Genes Involved in Learning

$3,284,735
Ronald L Davis · Scripps Research Institute, The · RC4 · FY2010 · AA

Functional Interrogation of Non-Coding Type 1 Diabetes Risk Variants in Human Immune Cells and Beta Cells

$3,282,897
Alexander Marson · University Of California, San Francisco · DP3 · FY2016 · DK

Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication

$3,282,801
Pamela J Lein · University Of California At Davis · U54 · FY2016 · NS

Clarifying the interplay between herpesvirus infection and reactivation, immune responses, APOE genotype, and development of tau-pathology

$3,280,861
Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health · RF1 · FY2025 · AG

Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication

$3,280,585
Pamela J Lein · University Of California At Davis · U54 · FY2015 · NS

Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication

$3,272,806
Pamela J Lein · University Of California At Davis · U54 · FY2014 · NS

Mechanisms, modeling and therapies of retinal and macular neurodegeneration

$3,271,791
Anand Swaroop · National Eye Institute · ZIA · FY2023 · EY

The AD Knowledge Portal Data Coordination Center

$3,261,591
Laura Michelle Heath · Sage Bionetworks · U24 · FY2024 · AG

Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck

$3,258,815
Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI

Metabolic factors that control the spectrum of human tuberculosis

$3,253,765
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2018 · AI

REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT

$3,253,754
Richard Schrock · Fisher Bioservices, Inc. · N02 · FY2023 · CA

CCR Office of Training and Education

$3,252,336
Jonathan Scott Wiest · Division Of Basic Sciences - Nci · ZIJ · FY2013 · CA

Track-2: The Smart MATerial Design, Analysis, and Processing (SMATDAP) consortium: Building next-generation polymers and the tools to accelerate cost-effective commercial productio

$3,251,051
Michael M Khonsari · Louisiana Board Of Regents · · FY2014 · O/D

Reagent Program for HIV and other Infectious Diseases

$3,250,651
Sujatha Rashid · American Type Culture Collection · N01 · FY2021 · AI

NCI Moonshot: NCI-DOE Collaboration

$3,250,000
Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA

Advancing novel cyanide countermeasures

$3,249,958
Calum A. Macrae · Brigham And Women'S Hospital · U54 · FY2019 · NS

Reagent Program for HIV and other Infectious Diseases

$3,248,336
Sujatha Rashid · American Type Culture Collection · N01 · FY2022 · AI

Alzheimer's Disease Genetics Consortium

$3,247,012
Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2014 · AG

COG NCTN Network Group Operations Center - Year 10 STAR Act COG) Outcomes & Survivorship (LTE) Committee

$3,243,049
Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA

South Dakota Biomedical Research Infrastructure Network

$3,241,731
Barbara E Goodman · University Of South Dakota · P20 · FY2016 · GM

The UCLA Center for Medical Countermeasures Against Radiation

$3,234,284
William H. McBride · University Of California Los Angeles · U19 · FY2017 · AI

FAMU RCMI Pharmaceutical Research Center

$3,233,212
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2014 · MD

fMRI Studies of Pediatric Mood and Anxiety Disorders

$3,233,142
Daniel Pine · National Institute Of Mental Health · ZIA · FY2023 · MH

Heartland Institute for Clinical and Translational Research

$3,225,880
Richard J. Barohn · University Of Kansas Medical Center · UL1 · FY2014 · TR

Development of Pre-Erythrocytic Malaria Vaccines

$3,223,147
Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI